product summary
company name :
Hycult Biotech
product type :
antibody
product name :
BPI, Human, mAb 3F9
catalog :
HM2041
quantity :
100 µg
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
3F9

The same clone is also sold as:
reactivity :
human
application :
blocking or activating experiments
more info or order :
citations: 2
Published Application/Species/Sample/DilutionReference
  • blocking or activating experiments; human; fig 6
Pinkenburg O, Meyer T, Bannert N, Norley S, Bolte K, Czudai-Matwich V, et al. The Human Antimicrobial Protein Bactericidal/Permeability-Increasing Protein (BPI) Inhibits the Infectivity of Influenza A Virus. PLoS ONE. 2016;11:e0156929 pubmed publisher
Canny G, Trifonova R, Kindelberger D, Colgan S, Fichorova R. Expression and function of bactericidal/permeability-increasing protein in human genital tract epithelial cells. J Infect Dis. 2006;194:498-502 pubmed
product information
Catalog no :
HM2041
Title :
BPI, Human, mAb 3F9
Clone no :
3F9
Quantity :
100 µg
Application code :
immunoassays
Species :
human
Host species :
mouse
Isotype :
IgG1
Conjugate :
purified
Aliases :
CAP57
Type :
mAb
Antigen :
BPI
Meta data :
CAP57
more info or order :
company information
Hycult Biotech
Frontstraat 2a
5405 PB UDEN
support@hycultbiotech.com
www.hycultbiotech.com
31 0 413 25 13 35
headquarters: Netherlands
Hycult Biotech develops, produces and markets antibodies, antibody based products and more specifically immunoassays for innate immunity and directly related fields, with an emphasis on complement, neutrophil proteins, TLR, scavenger receptors and acute phase proteins. Furthermore, we have a strong interest in progressing research in the area of inflammation and cell damage caused by pathogens or oxidation factors.

Hycult Biotech’s mission and strategy is to advance insight in innate immunity related diseases, for the benefit of individuals and their quality of life.

As a leader within focused fields of immunology and cell biology, we develop products for the life sciences and in accordance with our mission it is our ambition to facilitate the transition of these products from research use into diagnostic testing. Many of our reagents are developed in close cooperation with scientists worldwide. Hycult Biotech has built a strong network with over 40 close scientific collaborations with leading international research institutes. We contribute to numerous projects and as a result, can continuously offer early access to an expanding range of innovative reagents. Hycult Biotech has been ISO-9001 certified since 1998 and we upgraded our certification to ISO-13485 in 2007, with a milestone of our first release of CE marked assays in 2009. Our vision, knowledgeable team and quality management system guarantee products of the highest grade combined with excellent technical service.